Drug profile · INN
teriparatide acetate
PARATHAR
teriparatide acetate (PARATHAR) is a parathyroid hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — teriparatide acetate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
teriparatide acetate (PARATHAR) is a parathyroid hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Parathyroid hormone receptor agonist
Primary target: Parathyroid hormone/parathyroid hormone-related peptide receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is teriparatide acetate?
teriparatide acetate (PARATHAR) is a parathyroid hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for teriparatide acetate?
PARATHAR is a marketed brand name for teriparatide acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of teriparatide acetate?
teriparatide acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.